D. Walker

Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
202310 citationsauthor #8
Isolation of Human Microglia from Neuropathologically Diagnosed Cases in the Single-Cell Era.
20231 citationsauthor #2
Localization of Thioredoxin-Interacting Protein in Aging and Alzheimer’s Disease Brains
20222 citationsauthor #5
Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease.
202116 citationsauthor #5
Characterization of a Conformation-Restricted Amyloid β Peptide and Immunoreactivity of Its Antibody in Human AD brain.
202114 citationsauthor #13
Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease
20217 citationsauthor #42
Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
2020111 citationsauthor #3
Effects of FTMT Expression by Retinal Pigment Epithelial Cells on Features of Angiogenesis
20208 citationsauthor #2
Defining activation states of microglia in human brain tissue: an unresolved issue for Alzheimer’s disease
202029 citationsauthor #1
Linking CD200 in brains and dementia
20200 citationsauthor #1
Novel fluorinated derivative of curcumin negatively regulates thioredoxin-interacting protein expression in retinal pigment epithelial and macrophage cells.
202010 citationsauthor #2
Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains
2020101 citationsauthor #1
Does loss of interaction of progranulin and prosaposin promote neurofibrillary tangle development?
20200 citationsauthor #5
Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
201914 citationsauthor #1
Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease
201949 citationsauthor #31
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology
201952 citationsauthor #8
Alzheimer’s Disease Research Using Human Microglia
201923 citationsauthor #3
Differences in Gene Expression Profiles and Phenotypes of Differentiated SH-SY5Y Neurons Stably Overexpressing Mitochondrial Ferritin
201920 citationsauthor #3
Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
201964 citationsauthor #3
Defining Microglial Phenotypes in Alzheimer’s Disease
20180 citationsauthor #1
Defining Microglial Phenotypes in Alzheimer’s Disease Defining Microglial Phenotypes in Alzheimer’s Disease
20180 citationsauthor #1
Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models
20181 citationsauthor #5
Increased expression of toll‐like receptor 3, an anti‐viral signaling molecule, and related genes in Alzheimer's disease brains
201842 citationsauthor #1
Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity
2018153 citationsauthor #4
PINK 1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer ’ s disease
201722 citationsauthor #6
Apolipoprotein E Isoforms Differentially Regulate Alzheimer’s Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro
201728 citationsauthor #7
Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
2017101 citationsauthor #12
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
201732 citationsauthor #1
Neural Cell Degeneration in Human Retinas May Explain Visual Dysfunction in Parkinson Disease
20170 citationsauthor #3
PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease
2017258 citationsauthor #6
Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
2017105 citationsauthor #3
Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings
201712 citationsauthor #14
Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia
201782 citationsauthor #1
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s Disease
201673 citationsauthor #4
F1F0 ATP Synthase–Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline
201644 citationsauthor #9
Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
201632 citationsauthor #1
Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program
20161 citationsauthor #1
Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
201614 citationsauthor #5
Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program
201664 citationsauthor #1
Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease
201634 citationsauthor #9
A novel aspect of insulin neuroprotection in Alzheimer's disease: Modulation of glial cell-mediated neuroinflammation
20160 citationsauthor #3
P3‐156: Validating Plasma Metabolomics Signatures of Alzheimer’s Disease
20160 citationsauthor #2
Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models
201621 citationsauthor #5
Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings
201673 citationsauthor #14
Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells.
201564 citationsauthor #4
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
201583 citationsauthor #1
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
2015471 citationsauthor #1
Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.
201550 citationsauthor #1
EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING (SOCS) GENES IN HUMAN ELDERLY AND ALZHEIMER’S DISEASE BRAINS AND HUMAN MICROGLIA
20150 citationsauthor #1
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
20151 citationsauthor #1
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
2015407 citationsauthor #6
Vascular Factors and the Blood Brain Barrier in Alzheimer’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis
20150 citationsauthor #1
brain human functionally distinct regions of the normal aged Gene expression profiles in anatomically and
20151 citationsauthor #7
Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer’s disease
201570 citationsauthor #1
Submandibular gland needle biopsy for the diagnosis of Parkinson disease
2014118 citationsauthor #14
Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia.
201468 citationsauthor #6
Biochemical Assessment of Precuneus and Posterior Cingulate Gyrus in the Context of Brain Aging and Alzheimer’s Disease
201417 citationsauthor #3
Type 2 diabetes is associated with increased Alzheimer’s disease neuropathology in ApoE ε 4 Carriers
20142 citationsauthor #8
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices
2014145 citationsauthor #6
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
2013139 citationsauthor #1
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
201331 citationsauthor #7
Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology
201312 citationsauthor #7
Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status.
201359 citationsauthor #7
Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?
201353 citationsauthor #1
BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.
201312 citationsauthor #7
Title The influence of Apolipoprotein E genotype on regional pathology in Alzheimer ' s disease
20130 citationsauthor #7
Brain biochemistry in autopsied patients with essential tremor
201248 citationsauthor #8
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
201229 citationsauthor #4
Striatal Amyloid Plaque Density Predicts Braak Neurofibrillary Stage and Clinicopathological Alzheimer's Disease: Implications for Amyloid Imaging
201270 citationsauthor #3
P4‐048: Neurodegenerative‐related proteins in the evolution of the aging brain
20120 citationsauthor #2
Cerebral blood flow in Alzheimer’s disease
2012188 citationsauthor #13
Vascular Health and Risk Management Cerebral blood flow in Alzheimer ’ s disease
20120 citationsauthor #12
Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies
201262 citationsauthor #2
Cobalt(II) β-ketoaminato complexes as novel inhibitors of neuroinflammation.
201214 citationsauthor #6
Broad-Based Nutritional Supplementation in 3xTg Mice Corrects Mitochondrial Function and Indicates Sex-Specificity in Response to Alzheimer's Disease Intervention
201218 citationsauthor #11
Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging
201236 citationsauthor #4
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
201268 citationsauthor #7
Parkinson's disease, cortical dysfunction, and alpha‐synuclein
201120 citationsauthor #12
Postmortem interval effect on RNA and gene expression in human brain tissue
2011149 citationsauthor #2
Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease
201118 citationsauthor #8
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
201194 citationsauthor #6
Parkinson's Disease Dementia and Potential Therapeutic Strategies
201150 citationsauthor #4
Age-related differences in white matter integrity and cognitive function are related to APOE status
201187 citationsauthor #5
Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging
201172 citationsauthor #4
RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
2010319 citationsauthor #7
Amyloid load in nondemented brains correlates with APOE e4.
201089 citationsauthor #2
Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease
2010180 citationsauthor #4
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
2010852 citationsauthor #11
Author ' s response to reviews Title : Clinical and Postmortem Measures of Cardiac Pathology in Subjects with Alzheimer ' s Disease
20100 citationsauthor #6
Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology
2009184 citationsauthor #14
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
2009645 citationsauthor #18
ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides
2009195 citationsauthor #8
Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
2009269 citationsauthor #1
Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease.
200938 citationsauthor #4
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.
200951 citationsauthor #2
Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.
2009211 citationsauthor #3
Cholesterol retention in Alzheimer's brain is responsible for high β-and γ-secretase activities and Aβ production
2008255 citationsauthor #5
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
2008119 citationsauthor #11
Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
200816 citationsauthor #2
Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production.
2008139 citationsauthor #4

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT